Erschienen in:
25.10.2016 | Breast Oncology
Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement
verfasst von:
Todd M. Tuttle, MD, Andrea V. Barrio, MD, V. Suzanne Klimberg, MD, Armando E. Giuliano, MD, Mariana Chavez-MacGregor, MD, Heather A. Thompson Buum, Kelly M. McMasters, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 1/2017
Einloggen, um Zugang zu erhalten
Excerpt
The rates of contralateral prophylactic mastectomy (CPM) have markedly increased in the US over the past 2 decades.
1‐
3 These trends have been observed in all patient age groups, cancer stages, races, and in all geographic regions of the US. In the most recently published analyses from the Surveillance Epidemiology and End Results database, the CPM rates were still increasing with no plateau.
3 Most patients who undergo CPM do not have strong genetic or familial risk factors for developing contralateral breast cancer.
4 Recent survey studies have demonstrated that breast cancer patients substantially overestimate the risk of contralateral breast cancer and have unrealistic outcomes from CPM.
5,
6 Moreover, in a survey study among active members of the American Society of Breast Surgeons (ASBrS), Yao et al. concluded that 39.2 % of respondents had a ‘low level of knowledge about CPM’.
7 Given the gaps in knowledge among both patients and surgeons, the publication of the ASBrS consensus statement is timely. …
